UK Markets open in 5 hrs 17 mins

Nanobiotix S.A. (NNBXF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
9.100.00 (0.00%)
At close: 03:47PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close9.10
Open9.10
BidN/A x N/A
AskN/A x N/A
Day's range9.10 - 9.10
52-week range7.32 - 19.85
Volume100
Avg. volume132
Market capN/A
Beta (5Y monthly)2.23
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Business Wire

    CORRECTING and REPLACING: NANOBIOTIX Provides First Quarter Operational and Financial Update

    PARIS & CAMBRIDGE, Mass., May 19, 2022--Regulatory News: This replaces the announcement made at 4:40PM EDT/20:40 CEST on May 18 due to the following correction: Updated date in "First Quarter Operational Highlights" section.

  • Business Wire

    NANOBIOTIX Provides First Quarter Operational and Financial Update

    PARIS & CAMBRIDGE, Mass., May 18, 2022--Regulatory News: NANOBIOTIX (Euronext: NANO - NASDAQ: NBTX - the "Company"), a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer, today announced operational progress, cash position (unaudited) for the first quarter of 2022, and extension of operating runway into Q4 2023.

  • Business Wire

    NANOBIOTIX to Present During the Jefferies Healthcare Conference in June 2022

    PARIS & CAMBRIDGE, Mass., May 17, 2022--Regulatory News: NANOBIOTIX (Euronext : NANO –– NASDAQ: NBTX – the ‘‘Company’’), a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer, today announced that Laurent Levy, co-founder and chairman of the executive board, and Bart Van Rhijn, chief financial officer, will participate in the Jefferies Healthcare Conference in June 2022.